ЮРАК-ҚОН ТОМИР КАСАЛЛИКЛАРИ БЎЛГАНЛАРДА COVID-19 КОРОНАВИРУС ИНФЕКЦИЯСИНИНГ КЛИНИК АҲАМИЯТИ
Keywords:
Калит сўзлар: COVID-19, юрак-қон томир касалликлари, тропонин I, Д-димер, цитокинлар, миокард шикастланиши.Abstract
Аннотация: Юрак-қон томир касалликлари (ЮҚТК) мавжуд бўлган беморларда SARS-CoV-2 вируси келтириб чиқарадиган инфекция анча оғир кечади. Сурункали патологиялар фонида вирус гомеостазни тез бузиб юборади. Бу эса ўлим кўрсаткичининг ошишига сабаб бўлади. ЮҚТК билан хасталанган беморларда COVID-19 инфекциясининг клиник кечишини, лаборатор маркерлар динамикасини ва ушбу патологияларнинг ўзаро таъсирини баҳолаш.
References
1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
2. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7):811–818.
3. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiology. 2020;5(7):802–810.
4. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–1655.
5. Bansal M. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(3):247–250.
6. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiology. 2020;5(7):831–840.
7. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020;75(18):2352–2371.
8. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Progress in Cardiovascular Diseases. 2020;63(3):390–391.
9. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020;18(4):844–847.
10. European Society of Cardiology (ESC). ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic. European Heart Journal. 2020;41(19):1805–1807.
11. World Health Organization. Clinical management of COVID-19: Interim guidance. WHO; 2020.
